Carvedilol and metoprolol are both able to preserve myocardial function in type 2 diabetes.

Carol T BusseyAram A BabakrRachael R IremongerIsabelle van HoutGerard T WilkinsRegis R LambertsJeffrey R Erickson

Published in: Physiological reports (2021)

Metoprolol and carvedilol were found to have no effect on cardiac function in type 2 diabetes with preserved ejection fraction, and were similarly effective in preventing myocardial dysfunction in ZDF rats.

Keyphrases

type diabetes
ejection fraction
aortic stenosis
left ventricular
glycemic control
cardiovascular disease
insulin resistance
oxidative stress
heart failure
metabolic syndrome
skeletal muscle
coronary artery disease